PGE₂ signals through <i>Ptger2</i> to decrease <i>Sost</i> expression. by Damian C. Genetos (325684)

Overview of OmpA structure and points of allelic variation as previously described [46]. by Chunyu Liao (4436998)

MnTBAP treatment reduces caloric intake in mice fed a HFD. by Jonathan R. Brestoff (799142)

Real-time PCR confirmation of randomly selected genes whose expression levels were either increased (red) or decreased (green) by a specific endoxifen concentration. by John R. Hawse (227611)

“…Darkly shaded bars depict relative fold changes from E₂ (10 nM), TAM (300 nM), 4HT (7 nM) and NDT (700 nM) treated cells (combo/dashed line) as detected by microarray analysis while lightly shaded bars depict fold change as detected by RT-PCR analysis. …”

Modeling the Shape and Stability of Co Nanoparticles as a Function of Size and Support Interactions through DFT Calculations and Monte Carlo Simulations by Enrico Sireci (12127349)

Developmental regulation of the decrease in adhesion. by Marco Tarantola (102609)

Excessive LF4A kinase activity shortens cilia and decreases IFT. by Yu-Yang Jiang (7036916)

Data for Fig 5D. by Xiaohua Zhang (350570)

Defects in the conduction of somatosensory evoked potentials of median and tibial nerves in a healthy child and in H-ABC patient. by Jose R. Eguibar (8563227)

Subjects:

Homozygous deletion of <i>ERG251</i> results in decreased fitness at low initial cell density and increased fitness in the presence of low concentrations of FLC (≤1μg/ml). by Xin Zhou (54275)

Down-regulation of VCAN or THBS2 decreased the cell proliferation in A549 cells. by Tzu-Yang Weng (2938080)

PI3K activity is required for induction of cerebellar LTP. by Claire Jackson (362873)

Hypoxia and Cobalt decrease AQP5 mRNA by down-regulating AQP5 transcription. by Jitesh D. Kawedia (384551)

Irbesartan Decreases ¹⁴C-FDG and ^99mTc-annexin A5 Accumulation Levels. by Yan Zhao (58882)

Subjects:

miR-146a and miR-155 levels decrease at the convalescent stage in patients with <i>V</i>. <i>cholerae</i> O1 infection. by Aziz Bitar (257322)

Predicted distribution of boat sizes, given a 10 percentage point increase in the probability of interception. by Katherine Hoffmann Pham (11619125)

Increased BBB disruption, with a decrease in endothelial ZO-1, claudin-5 and occludin, avoided by GM6001. by Saran Feng (345936)

HealthRise patient shifts in disease severity categories between baseline and endline based on biometric readings for hypertension (A) and diabetes (B). by Nancy Fullman (243628)

Adenosine decreases the amplitude of evoked AMPA EPSCs via activation of A₁ ARs without altering that of the evoked IPSCs recorded from layer III pyramidal neurons in th... by Shouping Wang (402959)

“…<b>F,</b> Bath application of dipyridamole (1 µM), an adenosine transporter inhibitor, significantly reduced the evoked EPSCs (n = 10, p<0.001, paired t-test) suggesting that endogenously released adenosine decreases AMPA EPSCs. <b>G,</b> Prior application of DPCPX, an A₁ AR blocker, blocked dipyridamole-induced depression of AMPA EPSCs (n = 5, p = 0.85 vs. baseline, paired t-test) suggesting that the inhibitory effect of dipyridamole is mediated via activation of A₁ ARs. …”

P-Rex-deficient Purkinje neurons have normal passive membrane properties and basal synaptic transmission. by Claire Jackson (362873)